Oyster Point Pharma CEO Jeff Nau Taps Experience, Successful Network to Build Dry Eye Start-up

[creativ_pullleft colour=”light-gray” colour_custom=”” text=”Episode 167″]

Oyster Point Pharmaceuticals CEO Jeffrey Nau sheds some light on the new dry eye start-up, which is tapping much of the leadership and investment team that made Oculeve successful. He also talks about his own experiences leading high-profile clinical programs at Ophthotech and Genentech. What lessons will he bring into his new CEO role?